JGB-1-155

JGB-1-155
Clinical data
Drug classNAMPT positive allosteric modulator
Identifiers
  • N-[[4-(dimethylamino)phenyl]methyl]-N-[2-(2,2-dimethyl-4-propan-2-yloxan-4-yl)ethyl]furan-2-carboxamide
CAS Number
PubChem CID
ChemSpider
ChEMBL
Chemical and physical data
FormulaC26H38N2O3
Molar mass426.601 g·mol−1
3D model (JSmol)
  • CC(C)C1(CCOC(C1)(C)C)CCN(CC2=CC=C(C=C2)N(C)C)C(=O)C3=CC=CO3
  • InChI=1S/C26H38N2O3/c1-20(2)26(14-17-31-25(3,4)19-26)13-15-28(24(29)23-8-7-16-30-23)18-21-9-11-22(12-10-21)27(5)6/h7-12,16,20H,13-15,17-19H2,1-6H3
  • Key:XUAJYFDMEHVNTH-UHFFFAOYSA-N

JGB-1-155, is a drug which acts as a selective positive allosteric modulator of the enzyme nicotinamide phosphoribosyltransferase (NAMPT). It has neuroprotective effects, and was developed as a potential treatment for neurodegenerative diseases such as Alzheimer's disease.[1]

References

  1. ^ Gordon-Blake J, Ratia K, Weidig V, Velma GR, Ackerman-Berrier M, Penton C, et al. (February 2024). "Nicotinamide Phosphoribosyltransferase Positive Allosteric Modulators Attenuate Neuronal Oxidative Stress". ACS Medicinal Chemistry Letters. 15 (2): 205–214. doi:10.1021/acsmedchemlett.3c00391. PMC 10860701. PMID 38352833.
This article is issued from Wikipedia. The text is available under Creative Commons Attribution-Share Alike 4.0 unless otherwise noted. Additional terms may apply for the media files.